Toumaz Technology Debuts New Multi-Function Sensium Module

Toumaz Technology LimitedToumaz Technology Limited has announced the first availability of the Sensiumâ„¢ modular system, a new ultra-low power wireless infrastructure for health and lifestyle monitoring applications. The wireless-enabled modules, based on Toumaz's ultra-low power Zoum transceiver platform, are being made available now to key customers. The first demonstration of the new modular system took place on the Oracle stand at The World of Health IT Conference and Exhibition in Geneva, Switzerland (Geneva Palexpo, 10th-13th October 2006, Oracle stand #315).

The ultra small size body-worn module can be attached to the body with a sticking plaster to enable non-intrusive, continuous monitoring and analysis of the mobile individual's ECG, temperature, and at least one other vital sign such as respiration or activity level. The wearable sensor module incorporates Toumaz's ultra low power Zoum RF transceiver to create a wireless data link and transmit personal readings on to a Zoum-enabled SD card or USB module. The SD card plugs into any standard PDA or cellphone running Windows Mobile 5, allowing the ECG, temperature and other vital sign data to be received, processed and displayed via Toumaz's ECGSoft application software. A sophisticated, real-time arrhythmia detection algorithm continuously analyses the incoming data to provide an intelligent ECG monitoring capability.

Due to the ultra low power Zoum transceiver, incorporating both RF and baseband functionality such as framing, error correction and link protocol, the body-worn Sensium module is able to be manufactured in a small, non-intrusive form factor that can use a small, low cost zinc-air battery to provide multi-function continuous monitoring for an average of five days.

"The Sensium module is delivering the wireless infrastructure for a new wave of personalised care applications, and is now set to enable a real revolution in areas such as continuous vital sign monitoring," commented Toumaz COO, Keith Errey. "By integrating with standard mobile devices such as PDAs and cellphones, the Sensium is defining new possibilities for low cost, disposable monitoring solutions for a whole range of healthcare applications, including 'at risk', post-operative and home monitoring".

The 'digital plaster' concept pioneered by Toumaz has attracted significant interest within the healthcare market. Toumaz Chairman and Chief Technology Officer, Professor Chris Toumazou delivered an e-Session on Pervasive Monitoring Technologies for Personalised Healthcare at The World of Health IT Conference and Exhibition in Geneva.

For further information, please visit:
www.toumaz.com/healthcare/

Related news articles:

About Toumaz Technology
Toumaz Technology Limited is a developer of advanced RF, analogue and mixed signal semiconductors. The focus of the business is low power devices based on the company's proprietary AMx (Advanced Mixed Signal) technology which addresses the needs of lower power consumption for mobile and wirelessly connected systems.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...